Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 4

Status

Completed 5

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Plasma cell 5Thoracic 1Lymphoid 1Head & Neck 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 9Multiple Myeloma 5Neoplasms 4Neoplasm Metastasis 4Kidney Neoplasms 3Giant Cell Tumor of Bone 3Smoldering Multiple Myeloma 2Prostatic Neoplasms 2Lung Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer Metastatic 1Recurrence 1Parathyroid Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Osteoblastoma 1Neoplastic Cells, Circulating 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Inflammatory Breast Neoplasms 1Hypercalcemia 1Humoral Hypercalcemia Of Malignancy 1Hodgkin Disease 1Head and Neck Neoplasms 1Granuloma, Giant Cell 1

Interventions

Dexamethasone 337Bortezomib 187Lenalidomide 186Cyclophosphamide 166Melphalan 124Calcium Dobesilate 108daratumumab 95fludarabine phosphate 69carfilzomib 69pomalidomide 68Peripheral Blood Stem Cell Transplantation 64Filgrastim 56Thalidomide 55Busulfan 53Mycophenolic Acid 52Tacrolimus 45Granulocyte Colony-Stimulating Factor 45ixazomib 43fludarabine 42Whole-Body Irradiation 40Cyclosporine 35Etoposide 33dexamethasone acetate 31Antilymphocyte Serum 31isatuximab 29dexamethasone 21-phosphate 26Prednisone 26elotuzumab 25Biopsy 25auricularum 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Multiple Myeloma × Denosumab × Clear all
NCT02833610 2026-02-18

A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency

Massachusetts General Hospital

Phase 2 Completed
55 enrolled
Plasma cell

Multiple Myeloma

NCT03792763 2025-02-11

DEFENCE

Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase 2 Completed
8 enrolled
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

NCT00896454 2018-10-17

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Amgen

Phase 2 Completed
33 enrolled 22 charts
BreastGastrointestinalGenitourinaryHead & NeckLymphoidPlasma cellThoracic

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Endocrine Gland Neoplasms, Head and Neck Neoplasms, Hodgkin Disease, Hypercalcemia, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Parathyroid Neoplasms, Thyroid Neoplasms

NCT00259740 2017-03-15

Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab

Amgen

Phase 2 Completed
96 enrolled 7 charts
Plasma cell

Multiple Myeloma, Recurrence

NCT00104650 2011-01-24

Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates

Amgen

Phase 2 Completed
111 enrolled 20 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡